● --:--
Last updated 2026-06-09
SITM
SiTime Corporation
MEMS Precision Timing · AI Foundry & Connectivity
📌 Current holding · 2.60% NLV · initiated Jun 2026
$630.00
Mkt Cap ~$16.6B
52W: $186.49 – $901.81
Next earnings: 5 Aug 2026
⏸ Hold · Accumulate on weakness
Entry zone: $480–$560 · currently $630–675 (above zone)
⚠ Consensus estimates on Stockanalysis are stale (pre-8 May 2026 Q1 report). Revenue/EPS figures use IO Fund / management guidance per site trust hierarchy.
The market still prices SiTime as a niche component supplier; it misses that the shift from training to inference creates a structural 2×–4× step-change in timing content per rack, that the Renesas timing-unit acquisition transforms SITM into the only scaled, pure-play timing platform across the entire AI stack — from MEMS oscillators through CPO switches — with pricing power at every layer from 400G through 1.6T.
Fwd P/E (NTM, nGAAP)
~100×
PEG 2.98 (g=33.6% NTM)
3Y avg N/A — GAAP losses 2023–25; last profitable period: 39–128× (2022)6
Rev YoY (Q1 FY26)
+88.3%
QoQ +0.2% ↑ (re-accel from +66.3% Q4 FY25)1
Gross Margin (nGAAP)
64.5%
4Q ↑ (+7.1pp YoY); guided >65% Q21
FCF Margin (TTM)
14.3%
$54.27M TTM ⚠ SBC 27% of rev2
EPS Revision (90d)
↑↑↑ / ↓0
12 analysts · post-Q1 mass upgrade3
Next Earnings
5 Aug
Q2 FY26 · Est
CED Rev %
66.7%
$75.7M / $113.6M total1
CED Rev YoY
+158%
8th consecutive qtr triple-digit growth1
Thesis Durability
A−

Variant perception: Consensus models SITM as a cyclical MEMS component vendor; the market underestimates (1) the structural 2×–4× increase in timing content per inference rack vs training, (2) the CPO-switch transition driving 3× content uplift per switch, and (3) the Renesas acquisition converting SITM from a product company into a platform monopolist with 10× the clock IC portfolio and 10 new hyperscaler relationships. Market consensus FY2026 revenue of $489M is 20%+ below management's ≥80% growth guide of $588M+ — the repricing has only partially occurred.1,3

TAM: $10–11B timing TAM, expandable to $17–18B longer-term (management-stated at Q4 2025 call). The combined entity has a stated first milestone of $1B revenue (currently ~12% away).1

Structural tailwinds:
— Inference shift: newer XPUs require 2×–4× more timing content per system than training; GPU utilisation must rise from 20–40% to 50–60%, where synchronisation is mission-critical
— 1.6T adoption in 2026: higher ASPs than 800G as Elite 2 commands premium over prior Elite Super-TCXO
— CPO switches: timing content 3× higher vs pluggable, as optics move inside the switch
— Telecom AI convergence: AI-enabled 5G RAN designs contain 3× higher timing content1

Competitive moat: MEMS vs quartz provides 30–50% lower power, smaller footprint, higher shock/vibration resilience — structural, not just incremental. Chorus clock-SoC family integrates oscillators, clocks, resonators (6-week dev-time reduction, 50% board-area reduction). Elite 2 delivers 3× better synchronisation vs Elite. Post-acquisition: 500 differentiated clock products.1

Growth quality: Organic (MEMS is the core; Renesas adds portfolio breadth). Margin-accretive (CED carries above-average margins vs consumer). High ROIC on fabless MEMS. Moat trajectory: strengthening (product integration, platform completeness post-Renesas).

Bear-case stress-test: AI capex cycle pause would hit CED hard — SITM experienced a 49% revenue crash in FY2023 during the IoT/consumer trough, and while CED is structurally different, hyperscaler concentration risk is real. M&A integration risk with Renesas (complex $4B+ total deal). Some technical critique on SITM's MEMS jitter performance at certain frequency ranges exists (Irrational Analysis, various).7

Cyclicality check (Module B triggered — >50% revenue growth in semiconductor components): SITM's underlying business is historically cyclical (FY2022 peak → FY2023 −49% trough). CED is structurally differentiated from consumer/IoT cyclicality — 8 consecutive quarters of triple-digit growth with inference-driven tailwind suggests this is a structural shift, not a cyclical bounce. Cycle stage for CED: Mid Expansion. Trap risk for CED: LOW. Trap risk for consumer/IoT segment: MEDIUM — consumer is already in softness (-31% QoQ Q1). Overall peak-earnings trap: LOW for current trajectory given CED is ≥67% of revenue and accelerating.

Durable compounder with M&A inflection point. The inference timing-content thesis is structurally sound, the moat is strengthening, and the Renesas deal creates a platform company. The M&A execution risk is the primary caveat on thesis durability.
Business Quality
A−

Margin trajectory: Non-GAAP gross margin 64.5% (+7.1pp YoY) in Q1 FY26; guided >65% Q2. Mix shift towards CED (higher-margin) is the primary driver — roughly half from product mix, half from cost leverage. Q2 non-GAAP operating margin guided at 32.9%. GAAP operating margin remains negative (−10.9% Q1) due to ~27% SBC.1

FCF: Q1 FY26 FCF $17.9M (15.7% margin). TTM FCF $54.27M (14.3% of $379.9M TTM revenue). Strong improvement trajectory — was negative on FCF in FY2024. Operating cash flow TTM $103.3M (27.2% of revenue).2

SBC dilution (flagged): SBC was 27.1% of Q1 FY26 revenue ($30.7M on $113.6M). Annual SBC run-rate ~$109M. This is the primary quality caveat — economic FCF after SBC is negative on TTM GAAP basis. For the business to generate real shareholder value, SBC must decline as a % of revenue as the company scales.2

Balance sheet: Pre-acquisition: $788.6M cash, zero debt. Post-Renesas close: ~$488M cash, ~$1.2B 0% Convertible Senior Notes due 2031 → net debt ~$711M. No interest expense burden; repayment or conversion occurs 2031.5

EPS revisions (90d): Post-Q1 report (8 May 2026), analysts massively upgraded — Roth Capital to $900, Barclays to $850, Goldman Sachs to $800, UBS to $775, Needham to $850. All 12 analysts on the name moved targets up. Direction: entirely upward.4

Solvency screen: 🟢 CLEAN — 0% coupon converts impose no cash interest burden; $1.2B principal due 2031, by which time combined FCF should comfortably service repayment. Current ratio supported by $488M+ cash post-close. No going-concern language. Net debt/EBITDA post-close ~4× on TTM non-GAAP EBITDA (~$170M) but forward trajectory rapidly improves as combined entity scales. Debt maturity: single bullet 2031 (no near-term refinancing pressure).5

Flow signals:
  • Insider activity (Form 4, 90d): No confirmed cluster buy/sell found in open-access SEC EDGAR search. Headline report of "recent insider selling" noted (QuiverQuant, ~Jun 2026) — verify directly at EDGAR CIK 1451809 before acting on this.8
  • Short interest: 3.49% of float (15 May 2026) — below trigger threshold. Day-to-cover: 1.6 days. No squeeze or distress signal.7
  • Institutional ownership: 84.31%, 410 institutions. Morgan Stanley reduced by 35.2% in Q1 2026. Geode Capital and Ameriprise added. No tracked Dataroma superinvestor position change >25% found.8
Pristine non-GAAP engine, SBC overhang is the one blemish. Margins and cash flow are rapidly improving, balance sheet is clean, revisions are entirely positive — but 27% SBC is a real shareholder cost that must compress as revenue scales.
Entry Price Discipline
C+

Q1 FY26 beat/miss: Revenue $113.57M vs $103.45M consensus (+9.7% beat); non-GAAP EPS $1.44 vs $1.17 (+23.1% beat). Q2 guidance revenue $140–150M vs $112M consensus (+29% beat). FY2026 guide ≥80% vs ~59% prior consensus (+21%). The beat was unambiguous across every dimension.1,3

Valuation at $630:
— NTM non-GAAP P/E: ~100× (H2 FY26 + H1 FY27 blended EPS ~$6.33 using IO Fund/mgmt guidance)
— FY2026 non-GAAP P/E: ~108× (IO Fund: $5.81 EPS)
— FY2027 non-GAAP P/E: ~81× (IO Fund: $7.77 EPS)
— Semiconductor sector median fwd P/E: ~34–35× → SITM at 2.9× sector median
— PEG (NTM): 100 / 33.6 = 2.98 → RED (paying a hype premium)2,3,6

Multiple regime (Module C): Historical GAAP P/E is distorted by loss years 2023–2025. When profitable (2021–2022), SITM traded 39–309× GAAP P/E with a median ~105×. Current NTM non-GAAP P/E of ~100× sits at the Low-Median of SITM's own profitable history — not historically extreme for this name. However, mean-reversion to semiconductor sector median (34×) would subtract ~66% from total return independent of earnings growth. A great business at a premium multiple needs to grow through its valuation — at current price, SITM requires ~3–4 years of consensus growth merely to absorb the current multiple premium before meaningful price appreciation begins.6

DCF context: Standard 5-year FCF DCF (13% discount rate, bull case 35% CAGR from $100M FY2026 base → terminal at 5× FCF terminal growth) implies fair value ~$480–520/share. Current price of $630 sits ~20–31% above the DCF bull case. The market is pricing a 10+ year structural compounding story with full-confidence execution on the Renesas integration — a high bar.

My variant view vs consensus on earnings path: I believe FY2026 actual revenue will be $580–620M (above stale $489M consensus) once Renesas closes and analysts update models. The EPS path is genuinely above the stale consensus — this is a bull argument for the stock. However, even at more accurate $5.81 EPS (IO Fund/mgmt guide), the stock still trades at 108× FY2026 non-GAAP, which is full price. The repricing is partially (but not fully) done.

Distance from entry zone: Entry zone $480–$560. Current $630 is ~12–31% above the top of the entry zone. At the entry zone, SITM would be ~86–94× NTM non-GAAP P/E — still expensive vs sector, but consistent with SITM's own history and allowing a reasonable distribution of outcomes for a 26%+ CAGR over 3–5 years.

Entry price anomalies:
  • Stock peaked ~$901 on 15 May 2026 (post-Q1 euphoria), has pulled back ~30% to $630 on convert offering overhang ($1.2B at 0% coupon, May 2026) and profit-taking. The pullback has created a better entry vs $900 but entry zone not yet reached.
  • Barclays upgraded from Sell to Overweight post-Q1 (target $850) — capitulating bears are a short-term tailwind but also a signal that easy re-rating money is spent.
Priced to perfection relative to 5-year DCF — wait for the entry zone. The thesis is exceptional but current price is above both DCF scenarios on a standard 5-year basis; the market is already pricing the Renesas success and the 1.6T ramp with minimal margin for error.
Verdict — Existing Holding (2.60% NLV)
SITM is a high-conviction thesis — the inference-content step-change, Renesas platform transformation, and 1.6T ASP uplift are structural, not cyclical. Business quality is excellent and revisions are entirely positive. Position was initiated above the preferred entry zone ($480–$560); this doesn't invalidate the thesis but does reduce the margin of safety. Hold the 2.60% NLV position through the 5 Aug Q2 print and Renesas close. Do not add above $700. The 2.60% sizing reflects appropriate entry-price discipline given the premium valuation.
Hold 2.60% NLV. Add to 5–6% NLV on pullback to $480–560 if Q2 2026 print confirms CED growth ≥50% YoY and Renesas integration is on track. Trim to 1% NLV if revenue growth misses guidance or gross margin falls below 62%. No add above $700. 20% single-stock cap.
⚖ Opportunity-cost check
▾
vs CSPX (the floor)
SITM offers a unique pure-play on AI timing infrastructure with no CSPX exposure — the inference content step-change and platform monopoly narrative cannot be captured through broad market beta. At entry zone ($480–560), risk/reward is right-skewed vs CSPX's ~10–12% CAGR. At current $630, the margin over CSPX is thin on a 5-year DCF basis — the 2.60% sizing correctly reflects this risk-adjusted reality. Do not deploy further capital here over CSPX until price corrects.
vs current holdings
SITM stacks AI infrastructure exposure alongside AVGO (networking/custom silicon) and LITE (optical transceivers) — complementary rather than overlapping. It does not displace any current holding directly. The most natural comparison is LITE: both are AI connectivity infrastructure plays, but SITM has superior margin profile and platform defensibility. SITM at entry zone is preferable to adding LITE above its own entry zone.
✕ Thesis-breakers
▾

Three specific, observable data points that — if seen — force a sell or no-add.

  • 01CED segment revenue growth decelerates below 50% YoY for two consecutive quarters — signals inference timing content thesis is wrong or hyperscaler CapEx is pulling back materially. Watch from Q2 FY26 onward.
  • 02Renesas timing-unit integration produces combined non-GAAP gross margin below 62% in the first full year post-close (FY2027) — signals product overlap is worse than guided or pricing power in acquired portfolio is weaker than the 70% adj gross margin assumption.
  • 03SITM loses design-win position at any Tier-1 hyperscaler rack program (NVDA Blackwell Ultra, Rubin, or equivalent) to a quartz competitor — confirms the MEMS jitter/performance critique and invalidates the monopoly-pricing narrative. Any formal announcement of a competitive loss at hyperscaler level triggers re-evaluation.
⚠ Key risks
▾
  • 01Renesas integration risk: The deal is $4B+ total consideration (cash + equity). Renesas' timing unit has different customers, products, and culture. Failed integrations in semi M&A typically destroy 15–30% of the combined EV within 24 months. If the $300M FY2027 revenue target from the acquired unit misses by 20%, that alone reduces combined FY2027 EPS by ~$0.50–0.70 — significant at this multiple.
  • 02Hyperscaler CapEx concentration: CED is 66.7% of revenue and dominated by a handful of hyperscalers. Any pause, delay, or re-routing of AI infrastructure CapEx (as happened in early 2023 when Meta froze data centre spend) would crater CED revenue. SITM has no hedge against this — the FY2023 −49% experience shows how violent the downside can be. A 30% CED revenue decline would take FY2027 EPS below $3 and the stock below $250.
  • 03Convertible note dilution / balance sheet risk: $1.2B 0% converts due 2031. If stock is above conversion price at maturity, holders convert → ~1.1–1.5M additional shares (modest dilution at current price). If stock is below conversion price, company must repay $1.2B in cash. At $1.2B principal vs ~$488M post-close cash, this requires $700M+ in incremental FCF generation or refinancing by 2031 — achievable on current trajectory but not risk-free.5
  • 04MEMS performance criticism / competitive entry: A small but vocal technical critique argues that SiTime's MEMS oscillators have inferior jitter at certain frequency ranges vs best-in-class quartz. While this has not resulted in customer losses to date, broader adoption of NVIDIA's custom timing solutions or a quartz resurgence in high-performance 1.6T+ applications would compress SITM's premium pricing and the 3× CPO timing content thesis.7
  • 05SBC dilution ongoing: At 27.1% of Q1 FY26 revenue, annual SBC ~$110M+. SITM is issuing ~4M+ new shares annually between SBC, equity offerings, and Renesas consideration. True economic FCF (after SBC) is negative on TTM basis. If growth slows before SBC normalises, shareholder returns could disappoint despite strong non-GAAP metrics.
∑ DCF scenarios
▾

Discount rate: 13% — high-growth recently profitable, with new M&A leverage (net debt ~$711M post-Renesas close). FCF base year: FY2026E organic ($100M, 15–16% FCF margin on $588M+ guided revenue).

5Y FCF CAGR
35%
Terminal growth
5%
Fair value / share
~$480
vs current ($630)
−24%

Bull assumes: Renesas integration succeeds, combined FY2027 revenue $950M+, FCF scales from $100M (FY26) to $445M by FY31 at 35% CAGR with FCF margin expanding from 15% to 28%. Post-Renesas diluted share count: ~30.4M, net debt ~$711M. The bull scenario still implies current price is ~24% above DCF fair value — the market is pricing 10+ years of structural compounding with minimal execution risk, which is a high bar.

5Y FCF CAGR
20%
Terminal growth
5%
Fair value / share
~$185
vs current ($630)
−71%

Bear assumes: Renesas integration friction delays synergies by 18 months, organic CED growth decelerates to 30–40% YoY as hyperscaler capex normalises, FCF base $60M growing at 20% over 5 years. Consumer/IoT remains soft, no 1.6T premium materialises as forecast. At these assumptions, FCF reaches $149M by FY31 — still a solid business, but $185 fair value vs current $630 illustrates the multiple compression risk embedded at today's price.

Position: Current price ($630) is above BOTH scenarios. The market is discounting a structural monopoly story over a 10+ year horizon — valid thesis, but the standard 5-year DCF offers no margin of safety. Entry at $480–560 brings the bull case within 0–13% of current DCF fair value, a much more defensible distribution of outcomes.

Multiple regime context (Module C): SITM's GAAP P/E is not a useful 3Y average (three consecutive loss years, 2023–2025). When profitable (2021–22), SITM traded at 39–309× GAAP P/E with a median ~105×. At ~100× NTM non-GAAP P/E today, SITM is at the Low-Median of its own profitable history — not at an extreme by its own standards. However, any mean-reversion toward the semiconductor sector median (~34×) would require ~66% upward EPS growth just to keep the stock flat, making price appreciation heavily dependent on continued re-rating above sector median. The combined entity's expanded revenue base and improved FCF profile partially justify a sustained premium; the question is magnitude.

◷ Catalyst timeline
▾
  • 5 Aug 2026
    Q2 FY2026 earnings — guidance is $145M revenue and $1.93 non-GAAP EPS. A beat here validates the CED inference thesis in real time and could trigger further analyst upgrades. A miss would expose over-reaction risk in the current multiple.
  • H2 2026
    Renesas timing-unit acquisition close (HSR approved 8 May 2026; remaining regulatory/closing conditions). Announcement of close date creates near-term dilution overhang but is the single largest catalyst for combined-entity revenue re-rating — analysts currently working off stale organic-only estimates.
  • Q3–Q4 2026
    1.6T optical module volume ramp at hyperscalers. SiTime cited meaningful 1.6T adoption in 2026 driving higher ASPs vs 800G. Volume shipment confirmation in Q3 earnings (Oct/Nov 2026) would validate the ASP upgrade thesis and de-risk FY2027 estimates.
  • Q4 2026 – Q1 2027
    First combined-entity quarterly report post-Renesas close. Will reveal integration progress, Renesas CED revenue contribution, and combined gross margin trajectory toward the 65–67% guided range. This is the key "show me the numbers" moment for the M&A thesis.
“ Named analyst commentary
▾
"SiTime is seeing a clear inflection in its CED segment with 158% YoY and 17% QoQ growth in Q1. Management sees strong tailwinds due to a mix of increased unit volume of 3X from inference and higher ASPs, especially as we approach 1.6T. The acquisition of Renesas's timing unit is expected to boost the company's presence across the data center with new customer additions, while providing another lever for CED to expand. The company also offers a 65% gross margin, 30%+ operating margin and an 80% revenue growth guide for the year — with a healthy supply chain as the cherry on top. The setup in AI networking stocks moves quickly. SiTime is not for the passive investor and will require an active stance."
— Beth Kindig / IO Fund, 2026-05-08
Serenity (@aleabitoreddit): No coverage of SITM found in open-access posts.
Dylan Patel / SemiAnalysis (@SemiAnalysis): No specific SITM coverage found in free-tier content. SemiAnalysis has noted MEMS timing as an area of interest in the AI interconnect stack but has not published a dedicated SITM analysis accessible publicly.
Sources
1 IO Fund / Beth Kindig, "SiTime: Precision Timing Solutions Increasing in Importance, FY Revenue Growth Guide of >80%", 2026-05-08 (primary research; IO Fund figures used per site trust hierarchy)
2 StockAnalysis.com — SITM financials, cash flow, TTM data, accessed 2026-06-05
3 StockAnalysis.com — SITM forecast page (note: pre-Q1 stale consensus), accessed 2026-06-05; post-Q1 analyst price targets from Yahoo Finance / Quiverquant, 2026-05-07
4 Yahoo Finance, Quiverquant — analyst rating changes post-Q1, 2026-05-07 to 2026-05-09
5 SEC EDGAR — SITIME Corp Form 8-K (convertible note offering), 2026-05-19; Form 8-K (Renesas acquisition agreement), 2026-02-04; HSR clearance, 2026-05-08
6 Macrotrends — SITM historical P/E 2020–2025, accessed 2026-06-09
7 Ad-hoc-news.de, short interest data 2026-05-15; Irrational Analysis Substack (technical critique reference, no date), accessed 2026-06-09
8 Fintel.io (free tier) — institutional ownership 84.31%, 410 institutions; 13F data carries 45-day lag 45-day lag

⚠ = figure not verifiable from open-access sources or from a single provider. Form 4 insider selling noted in headlines — not independently confirmed from EDGAR Form 4 filings; verify at sec.gov/cgi-bin/browse-edgar?CIK=1451809&type=4.